Translational Development Acquisition Corp. (TDAC) and ProLogium Holding Inc. describe a proposed business combination intended to take ProLogium public, alongside a proposed private investment in public equity (PIPE). The transaction targets a pre-money enterprise value of ~$3.8 billion; the presentation also gives a pre-money equity valuation of ~$3.9 billion, adjusted for $100 million of ProLogium net cash. The parties are targeting ~$300 million of incremental gross proceeds for ProLogium from anticipated PIPE proceeds and TDAC cash in trust.
At closing, ProLogium is seeking ~$370 million of net cash, comprising the targeted gross proceeds, less $30 million of transaction expenses, plus existing net cash. Closing is targeted for the second half of 2026 and remains subject to conditions including the $250 million Minimum Cash condition.
Translational Development Acquisition Corp. (TDAC) is the blank-check company in a definitive business combination agreement with ProLogium, which plans to unveil its GEN4 battery at the Paris Motor Show. GEN4 incorporates ProLogium’s Superfluidized Inorganic Electrolyte, which forms a Dynamic Coordination Network that ProLogium describes as a third lithium-ion transport mechanism. SGS-witnessed tests reported ionic conductivity of up to 57 mS/cm at room temperature; ProLogium’s internal testing reported charging from 5% to 80% in 6.4 minutes, more than 1,000 fast-charge cycles, more than 90% capacity retention at -20°C and discharge rates reaching 15C.
Mercedes-Benz has priority access to GEN4 cells under a joint testing agreement, while FEV and OPmobility plan to showcase a battery module and a battery-pack prototype. ProLogium expects a 90% recovery rate for SFIE in its recycling process. Construction continues at its Dunkirk factory; the first phase is designed for 4.0 GWh of annual capacity, expected to be progressively achieved by 2030, and the site has a maximum designed production capacity of up to 44.0 GWh. Subject to completion of the business combination, applicable approvals and listing conditions, ProLogium is expected to list on Nasdaq under proposed ticker PRLG.
Translational Development Acquisition Corp. (TDAC) is party to a definitive business combination agreement with ProLogium Holding Inc. ProLogium and Mercedes-Benz AG have signed a joint testing agreement giving Mercedes-Benz priority access to ProLogium’s Gen4 battery cells. Electrical, thermal and safety testing will assess the cells’ suitability for potential use in future vehicles.
ProLogium’s planned Dunkirk facility has a maximum designed capacity of up to 44.0 GWh. Its first phase is designed for 4.0 GWh of annual production capacity, expected to be progressively achieved by 2030. ProLogium is expected to list on Nasdaq under proposed ticker PRLG, subject to completion of the business combination, applicable approvals and listing conditions.
Translational Development Acquisition Corp. (TDAC) distributed information from ProLogium Holding Inc. describing a strategic investment by Kyushu Electric Power in ProLogium, extending their relationship from industrial collaboration into capital participation. The companies plan to continue joint work on next-generation batteries, including exploring battery module manufacturing in Japan for demanding industrial and construction machinery applications.
The communication also outlines ProLogium’s next-generation lithium ceramic battery business, its Taoyuan GWh-class gigafactory and a second gigafactory in Dunkirk, France, and reminds TDAC shareholders that a registration statement on Form F-4 with a proxy statement/prospectus has been filed for the proposed business combination between ProLogium and TDAC.
Translational Development Acquisition Corp. is a SPAC that has not yet begun operating activities and is focused on completing its first business combination. As of June 30, 2026, assets totaled $157.4 million, largely in a trust account invested in money market funds, with cash outside the trust of $85,877 and a working capital deficit.
For the six months ended June 30, 2026, the company reported net income of $2.3 million, driven by $3.3 million of dividends on trust investments, partially offset by $0.9 million of general and administrative costs. During June 2026, holders redeemed 2,598,697 Class A shares for $27.8 million, reducing trust assets.
The SPAC entered into a Business Combination Agreement with ProLogium Holding Inc. and a related $50 million subscription for 5,000,000 Class A shares plus an equal number of warrants, both contingent on closing the transaction. The combination deadline was extended to June 24, 2027, but management discloses substantial doubt about the ability to continue as a going concern if no deal is completed by that date.
Meteora Capital, LLC and its managing member Vik Mittal report beneficial ownership of 919,000 shares of Translational Development Acquisition Corp. Class A Common Stock, representing 6.27 % of the class. All reported shares are held by funds and managed accounts for which Meteora Capital acts as investment manager, with no sole voting or dispositive power and shared voting and dispositive power over all 919,000 shares. The reporting persons state that the filing does not constitute an admission that they are beneficial owners of these shares for purposes of Section 13.
Linden Capital L.P., Linden GP LLC, Linden Advisors LP and Siu Min (Joe) Wong report beneficial ownership of 1,150,000 Class A Ordinary Shares of Translational Development Acquisition Corp. as of June 30, 2026. This represents approximately 6.7% of the outstanding Class A shares for each of Linden Advisors and Mr. Wong, and 1,109,668 shares, or 6.4%, for each of Linden Capital and Linden GP. The 1,150,000 shares consist of 1,109,668 shares held by Linden Capital and 40,332 shares held in separately managed accounts. All reported voting and dispositive powers are shared, with no sole voting or dispositive power reported by any party.
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC report beneficial ownership of 1,056,879 Class A ordinary shares of Translational Development Acquisition Corp. Both entities report 7.2% of the class.
They report 0 shares with sole voting or dispositive power and 1,056,879 shares with shared voting and shared dispositive power. Goldman Sachs & Co. LLC is identified as a broker-dealer and registered investment adviser, and as a subsidiary through which the parent holding company’s reportable ownership is held.
The reporting units of Goldman Sachs state that they disclaim beneficial ownership of securities held for certain client accounts or investment entities where interests are held by other persons.
ProLogium Holding Inc. and Translational Development Acquisition Corp. (TDAC) outline a US$50 million committed primary capital investment from a consortium of existing shareholders to support their proposed business combination and ProLogium’s commercialization plans for next-generation lithium ceramic batteries.
ProLogium highlights its technology position, with over 1,100 global patents, more than 2.4 million battery products delivered and about 10,000 samples supplied for automotive applications. Its Taoke facility in Taiwan is described as the first commercial next-generation lithium ceramic battery gigafactory to publicly display its production line.
The company is expanding in Europe through an R&D center in Paris-Saclay and a gigafactory project in Dunkirk, France, where Phase 1 is designed for 4.0 GWh capacity by 2030 and the full site for up to 44.0 GWh. The communication also notes that ProLogium has filed a Form F-4 registration statement that includes a proxy statement/prospectus for TDAC shareholders regarding the transaction.
ProLogium Holding Inc. and special purpose acquisition company Translational Development Acquisition Corp. (TDAC) announced a $50 million committed primary capital investment from a consortium of existing ProLogium shareholders to support their proposed business combination that would result in ProLogium becoming publicly listed. The capital is part of a broader raise tied to the transaction and is expected to help scale production of ProLogium’s next-generation lithium ceramic batteries, advance construction of its gigafactory in Dunkirk, France, and fund expansion into applications such as data centers, aerospace and robotics.
ProLogium highlights more than 1,100 global patents, over 2.4 million battery products delivered and a first GWh‑class gigafactory in Taoyuan, Taiwan. The Dunkirk site is planned for a Phase 1 capacity of 4.0 GWh by 2030 and a maximum designed capacity of 44.0 GWh. The communication also references ProLogium’s filed Form F‑4 registration statement and associated proxy statement/prospectus for TDAC shareholders.